Monoclonal antibodies (mAbs) are large, complex glycoproteins whose therapeutic activity depends on maintaining structural integrity and highly specific binding to molecular targets. Their size, conformational sensitivity, and susceptibility to interfacial and mechanical stresses make aerosolization a significant formulation and device challenge.